Related Experiment Video

Updated: Jul 21, 2026

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)

Published on: April 24, 2017

[Rationale for coronary recanalization using transluminal atherectomy]

M Marzilli1

  • 1Istituto di Fisiologia Clinica del CNR, Università degli Studi, Pisa.

Cardiologia (Rome, Italy)
|December 1, 1994
PubMed

Insights

Simpson's atherocath removes atherosclerotic plaques, offering a novel approach to coronary artery disease treatment. While current studies show limited clinical benefit over balloon angioplasty, evolving atherectomy technology holds future promise.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Context:

  • Balloon angioplasty, a standard treatment for coronary artery disease, faces limitations including acute occlusion and late restenosis.
  • New devices aim to overcome these limitations, with Simpson's atherocath designed to remove atherosclerotic plaques.

Purpose:

  • To evaluate the efficacy and limitations of Simpson's atherocath in treating coronary artery disease.
  • To compare atherectomy with traditional balloon angioplasty in terms of acute luminal gain and clinical outcomes.

Summary:

  • Simpson's atherocath removes atherosclerotic plaques but its use is restricted to proximal, non-tortuous coronary vessels (≥2.5 mm) due to device size and stiffness.
  • Comparative studies indicate greater acute luminal gain with atherectomy versus balloon angioplasty, but this has not translated into proven clinical advantage.
  • Atherectomy technology is rapidly advancing, suggesting future iterations may offer improved clinical outcomes.

Impact:

  • Atherectomy provides a unique platform for studying vascular wall pathology.
  • Further technological advancements in atherectomy devices and treatment strategies may redefine its role in managing coronary artery disease.
  • This research highlights the ongoing evolution of interventional cardiology techniques for treating complex vascular conditions.

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...